FindTrial
Sign In

Comparison of the cumulative clinical outcomes of Poseidon 3 group patients treated with the follicular-phase depot GnRH agonist protocol and the antagonist protocol: a randomized controlled single-center study

Comparison of the cumulative clinical outcomes of Poseidon 3 group patients treated with the follicular-phase depot GnRH agonist protocol and the antagonist protocol: a randomized controlled single-center study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400095021
Enrollment
Unknown
Registered
2024-12-31
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility

Interventions

the follicular-phase depot GnRH agonist protocol group:follicular-phase depot GnRH agonist protocol
the antagonist protocol group:antagonist protocol

Sponsors

Jiangxi Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) Age: 20-35 years old, (2) Patients undergoing IVF/ICSI for the first time, or patients undergoing IVF/ICSI for the second time (no embryos remaining from the previous time) (3) AMH < 1.2 ng/ml or AFC < 5 (on the day of the protocol) (4) 18.5 < BMI < 28 kg/m^2 (5) Signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Repeated implantation failure and recurrent miscarriage (2) Severe uterine malformation, severe intrauterine adhesions, adenomyosis and other uterine abnormalities that affect pregnancy (3) PGT cycle (4) Combined with antiphospholipid syndrome, thyroid or adrenal dysfunction, severe liver and kidney damage and other diseases that are not suitable for pregnancy in the short term.

Design outcomes

Primary

MeasureTime frame
Cumulative live birth rate;—

Countries

China

Contacts

Public ContactZhaoYan

Jiangxi Maternal and Child Health Hospital

zhaoyan1972009@163.com+86 791 8272 3617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026